Yearly zoledronic acid in postmenopausal osteoporosis.
Najib
Marwan A
MA
Aziz
Imran
I
D050071:Bone Density Conservation Agents / Q000008:administration & dosage*; D004164:Diphosphonates / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D005260:Female; D050723:Fractures, Bone / Q000517:prevention & control*; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage*; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy*; D010919:Placebos; D012107:Research Design; D000077211:Zoledronic Acid
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D007093:Imidazoles; D010919:Placebos; D000077211:Zoledronic Acid